| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.61 | 0.004 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.57 | 0.008 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.54 | 0.01 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.52 | 0.02 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.46 | 0.02 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.46 | 0.3 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.45 | 0.02 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.44 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.43 | 0.009 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.4 | 0.03 |